P-274 Rigosertib activity in patients with a myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) relapsed or refractory to hypomethylating agents
| Autor: | Navada, S.C., Odchimar-Reissig, R., Reddy, E.P., Demakos, E.P., Holland, J.F., Wilhelm, F., Silverman, L.R. |
|---|---|
| Zdroj: | In Leukemia Research May 2013 37 Supplement 1:S146-S146 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect